186 related articles for article (PubMed ID: 2103495)
1. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies.
Gerdes J
Semin Cancer Biol; 1990 Jun; 1(3):199-206. PubMed ID: 2103495
[TBL] [Abstract][Full Text] [Related]
2. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.
Key G; Becker MH; Baron B; Duchrow M; Schlüter C; Flad HD; Gerdes J
Lab Invest; 1993 Jun; 68(6):629-36. PubMed ID: 7685843
[TBL] [Abstract][Full Text] [Related]
3. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.
Gerdes J; Li L; Schlueter C; Duchrow M; Wohlenberg C; Gerlach C; Stahmer I; Kloth S; Brandt E; Flad HD
Am J Pathol; 1991 Apr; 138(4):867-73. PubMed ID: 2012175
[TBL] [Abstract][Full Text] [Related]
4. [In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer)].
Lellé RJ
Acta Histochem Suppl; 1990; 39():109-24. PubMed ID: 2080254
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
Gerdes J; Lemke H; Baisch H; Wacker HH; Schwab U; Stein H
J Immunol; 1984 Oct; 133(4):1710-5. PubMed ID: 6206131
[TBL] [Abstract][Full Text] [Related]
6. Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7).
Guillaud P; du Manoir S; Seigneurin D
Anal Cell Pathol; 1989 Feb; 1(1):25-39. PubMed ID: 2488698
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas.
Sabattini E; Gerdes J; Gherlinzoni F; Poggi S; Zucchini L; Melilli G; Grigioni F; Del Vecchio MT; Leoncini L; Falini B
J Pathol; 1993 Apr; 169(4):397-403. PubMed ID: 8099126
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67.
Duchrow M; Schlüter C; Wohlenberg C; Flad HD; Gerdes J
Cell Prolif; 1996 Jan; 29(1):1-12. PubMed ID: 8603106
[TBL] [Abstract][Full Text] [Related]
9. Ki-S1--a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapy.
Kuropkat C; Rudolph P; Parwaresch R; Werner JA
Anticancer Res; 2003; 23(5A):3965-70. PubMed ID: 14666704
[TBL] [Abstract][Full Text] [Related]
10. HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues.
Todorov IT; Werness BA; Wang HQ; Buddharaju LN; Todorova PD; Slocum HK; Brooks JS; Huberman JA
Lab Invest; 1998 Jan; 78(1):73-8. PubMed ID: 9461123
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen.
Rudolph P; Knüchel R; Endl E; Heidebrecht HJ; Hofstäder F; Parwaresch R
Mod Pathol; 1998 May; 11(5):450-6. PubMed ID: 9619598
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
13. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
Steck K; el-Naggar AK
Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
[TBL] [Abstract][Full Text] [Related]
14. Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes--a comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions.
Thiele J; Bertsch HP; Kracht LW; Anwander T; Zimmer JD; Kreipe H; Fischer R
J Pathol; 1994 May; 173(1):5-12. PubMed ID: 7523642
[TBL] [Abstract][Full Text] [Related]
15. The Ki-67 protein: from the known and the unknown.
Scholzen T; Gerdes J
J Cell Physiol; 2000 Mar; 182(3):311-22. PubMed ID: 10653597
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
17. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.
Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R
Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150
[TBL] [Abstract][Full Text] [Related]
18. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
20. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]